+1-947-333-4405
+1-947-333-4405Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Infectious Diseases & Therapy received 1529 citations as per Google Scholar report
Maria S. Salvato received her BA at UCLA and a doctorate in Virology at UCBerkeley in 1979. She did post-doctoral studies at UCSF on RNA Processing with Dr. Christine Guthrie. 1980 she became a Sr Scientist at the MRC- Cambridge UK, under the direction of Sydney Brenner. In 1985 she joined Michael Oldstones group at the Scripps Research Foundation where she completed the first arenavirus sequence and discovered the zinc-binding gene product of the arenaviruses. From 1990-2000 she was a faculty member at the University of Wisconsin, Madison, where she developed a primate model for viral hemorrhagic fever. Dr. Salvato is currently a Professor at the Institute of Human Virology, University of Maryland Medical School. She has been active on NIH study sections, has chaired the ICTV-Arenavirus Group from 2000-2011, and has served on an Institute of Medicine panel on Smallpox.
The Salvato laboratory investigates virus-host interactions using animal models, genomic profiling, and basic molecular virology. Recent studies explored arenavirus pathogenesis using non-human primate models for Lassa fever. Lassa fever vaccine research, has resulted in two live-attenuated candidates: one (ML29) is a reassortant between Lassa virus and Mopeia virus, and the other (YF/LAS) is a recombinant between the Yellow Fever vaccine (YF17D) and the Lassa glycoprotein. The ML29 candidate is broadly cross-reactive and protects primates from Lassa fever. The YF/LAS is effective in protecting guinea pigs but not primates. Current studies explore adjuvants to DNA vaccination that require Treg suppression.
Complications of Bariatric Surgery: What can IR do?
| Mario Corona, Chiara Zini, Pierleone Lucatelli, Alessandro d’Adamo, Maria Rosignuolo and Filippo Maria Salvatori |
| Commentary: OMICS J Radiol 2013, 2: 148 |
| DOI: 10.4172/2167-7964.1000148 |
| Mario Corona, Antonio Bruni, Chiara Zini, Emanuele Boatta, Fabio Coratella, Jacopo Tesei, Paolo Rabuffi, Carlo Cirelli, Fabrizio Fanelli and Filippo Maria Salvatori |
| Case Report: OMICS J Radiology 2013, 2: 145 |
| DOI: |
| Dermot Cox, Maria S Salvato and Juan Carlos Zapata |
| Review Article: J Bioterror Biodef 2013, S12:003 |
| DOI: 10.4172/2157-2526.S12-003 |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
